Eric C Breinlinger

Title: The Innovative Contributions of Eric C Breinlinger

Introduction

Eric C Breinlinger is a notable inventor based in Charlton, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Breinlinger has made strides in developing compounds that target critical biological pathways.

Latest Patents

Among his latest patents is a groundbreaking work on "Inhibitors of tyrosine kinase 2 mediated signaling." This patent discloses compounds of Formula (I) and their pharmaceutically acceptable salts, which are designed to modulate signaling pathways. Another significant patent is focused on "Indazolones as modulators of TNF signaling." This disclosure provides compounds of Formula (I), including pro-drugs and biologically active metabolites, which are useful for treating immunological and oncological conditions.

Career Highlights

Breinlinger has had a distinguished career, working with prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Throughout his career, Breinlinger has collaborated with esteemed colleagues, including Michael M Friedman and Maria A Argiriadi. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Eric C Breinlinger exemplifies the spirit of innovation in the pharmaceutical industry through his patents and collaborations. His work continues to influence the development of new treatments for various medical conditions.